Cationic antimicrobial peptides
A method for treating an infection comprises administering a peptide in synergistic combination with an antibiotic, wherein the peptide comprises an amino acid sequence with a formula selected from the group consisting of: B n1 -Z; (a) B n1 -Z-B n2 ; and (b) Z-B n1 (c) wherein B is a basic amino acid residue; n1 and n2 are 1 to 6; and Z is a sequence of from about 7 to about 24 amino acid residues, said sequence having an average hydrophobicity value of at least 0.3 on the Liu-Deber scale.
1. A method for penetrating a bacterial biofilm, the method comprising administering a peptide to a biofilm, the peptide consisting of the amino acid sequence KKKKKKAAFAAWAAFAA-NH 2 (SEQ ID NO:3), wherein penetrating comprises binding to and passing through the bacterial biofilm.
2. The method of claim 1 , wherein the amino acids in the peptide are D-amino acids, L-amino acids, or a combination thereof.
3. The method of claim 1 , wherein the peptide is a stapled peptide.
4. The method of claim 3 , wherein the stapled peptide is a helix stapled peptide.
5. The method of claim 1 wherein the peptide is administered in synergistic combination with an antibiotic.
6. The method of claim 5 , wherein the antibiotic is selected from the group consisting of aminoglycosides, fluoroquinolones, carbapenem beta-lactam antibiotics, and combinations thereof.
7. The method of claim 6 , wherein the antibiotic is selected from tobramycin, ciprofloxacin, meropenem, and combinations thereof.
8. The method of claim 1 , wherein the bacterial biofilm is associated with sinusitis, a urinary tract infection, a middle-ear infection, dental plaque, gingivitis, contact lenses, endocarditis, cystic fibrosis, permanent indwelling devices such as joint prostheses, heart valves, catheters, and intrauterine devices, cutaneous wounds, or a surface that requires cleaning.
9. A method of decreasing the pathology of a P. aeruginosa infection associated with a bacterial biofilm in a subject, the method comprising administering a composition comprising a peptide consisting of the amino acid sequence KKKKKKAAFAAWAAFAA-NH 2 (SEQ ID NO:3) and an antibiotic selected from the group consisting of tobramycin, ciprofloxacin, and meropenem to the subject, wherein the peptide binds to and passes through the bacterial biofilm.